Naba Alsaha Medical Services Company
Naba Alsaha Medical Services Company (9546.SR) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
9546.sr · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Naba Alsaha Medical Services Company (9546.SR) measures how much investors pay for each dollar of the company's trailing earnings. 9546.SR's current PE ratio of 17.44x is calculated by dividing its stock price of $22.85 by its TTM earnings per share of $1.31. −7.5% discount vs 5Y avg 18.9x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2020 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 6 fiscal years · Front-end computedMinQ1 · 25%14.0x
MedianQ3 · 75%38.1x
Max
At 17.44x, 9546.SR's current P/E is within its average historical range over the past 6 fiscal years.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Care Facilities · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Naba Alsaha Medical Services CompanyYou 9546.SR | $480M | 17.44x | -42.3% | $1.31 |
 Canadian General Medical Center Complex Company 9518.SR | $697M | 52.86x | +75.0% | $0.13 |
 Ame Company For Medical Supplies 9527.SR | $511M | 19.00x | -37.1% | $5.00 |
 Arabian International Healthcare Holding Company 9530.SR | $420M | 18.71x | -38.1% | $1.20 |
 Professional Medical Expertise Co. 9574.SR | $300M | 8.14x | -73.1% | $11.92 |
 Lana Medical Co. 9587.SR | $151M | 48.80x | +61.5% | $0.05 |
 Almujtama Alraida Medical Co. 9592.SR | $234M | 33.75x | +11.7% | $0.88 |
Industry Average 6 peers with valid PE | — | 30.21x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 18.70x | $1.31 | -50.9% | |
2024-12-31 FY2024 | 38.08x | $1.04 | +216.6% | |
2023-12-31 FY2023 | 12.03x | $2.49 | +7.5% | |
2022-12-31 FY2022 | 11.19x | $1.28 | -21.6% | |
2021-12-31 FY2021 | 14.26x | $1.23 | +3.2% | |
2020-12-31 FY2020 | 13.82x | $1.27 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Naba Alsaha Medical Services Company (9546.SR) measures how much investors pay for each dollar of the company's trailing earnings. 9546.SR's current PE ratio of 17.44x is calculated by dividing its stock price of $22.85 by its TTM earnings per share of $1.31.
Frequently asked questions
9546.SR pe ratio · 6 questions9546.SR's current PE ratio is 17.44x as of 2026-06-15, based on a stock price of $22.85 and TTM EPS of $1.31. Data sourced from Financial Modeling Prep via 9546.SR's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Naba Alsaha Medical Services Company SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-15